MarketsandMarkets Blog

The United States immunoassay market is a highly advanced and rapidly growing sector within the broader diagnostics industry, driven by an aging population and the increasing prevalence of chronic and infectious diseases. The landscape is characterized by a significant shift toward laboratory automation and the integration of artificial intelligence to enhance diagnostic sensitivity and streamline...

The United States life science analytics market is a mature and dominant ecosystem characterized by high healthcare digitization and robust investment in research and development. The landscape is defined by the widespread adoption of artificial intelligence and machine learning to manage the increasing complexity of biomedical data from clinical trials, genomics, and electronic health records. Major...

The United States cancer biomarkers market is a highly sophisticated and rapidly expanding sector, driven by a robust healthcare infrastructure and substantial research and development investments. The landscape is defined by a significant shift toward precision medicine and personalized oncology, where biomarkers are increasingly used for early detection, treatment selection, and monitoring. Technological...

The United States immunotherapy drugs market is a rapidly expanding and highly advanced sector of the healthcare industry, serving as a global epicenter for biotech innovation and drug development. This landscape is characterized by a significant shift toward precision medicine, with the market increasingly dominated by innovative therapies such as monoclonal antibodies, immune checkpoint inhibitors,...

The United States molecular diagnostics market is a mature and technologically advanced sector characterized by robust research and development investments and a well-established healthcare infrastructure. Driven by the rising prevalence of chronic and infectious diseases, the market is shifting toward personalized medicine and the decentralization of testing through point-of-care and near-patient...

The United States ultrasound market is a mature yet rapidly evolving sector characterized by a significant shift from traditional stationary platforms toward AI-driven, portable, and point-of-care solutions. Driven by an aging population and a rising prevalence of chronic conditions like cardiovascular diseases and cancer, the landscape is defined by high demand for non-invasive diagnostic tools across...

The United States infusion pump market is a sophisticated and growing sector of the healthcare industry, driven by an aging population and a high prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases. The market landscape is defined by a significant shift toward patient-centered care, evidenced by the rising adoption of ambulatory and home-based infusion therapies which...

The United States proteomics market is a highly advanced and rapidly growing sector, serving as a global leader in the large-scale study of protein structures and functions. The landscape is characterized by robust research and development activities, significant government and private funding—exemplified by substantial NIH investments—and a strong presence of key industry players like Thermo Fisher...

The United States digital PCR market is a rapidly advancing sector of the molecular diagnostics industry, valued at approximately USD 1.6 billion in 2025 and projected to reach USD 8.2 billion by 2034. The landscape is characterized by a strong emphasis on precision medicine and the increasing adoption of droplet digital PCR technology, which accounts for the largest market share due to its high sensitivity...

The United States flow cytometry market is a sophisticated and rapidly advancing sector that serves as a cornerstone for both clinical diagnostics and biomedical research. This market is primarily fueled by a strong domestic research and development ecosystem, supported by significant public and private funding and a high burden of chronic diseases such as cancer and immunological disorders. The landscape...